Global Wealth Strategies & Associates’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Global Wealth Strategies & Associates’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50	Closed	-$20	–	367
2023 Q3	$20	Buy	+50	New	+$25	﹤0.01%	335

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Global Wealth Strategies & Associates's BLPH Position: Q4 2023 in Review

Global Wealth Strategies & Associates sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 50 shares — an estimated $20 sold.

Global Wealth Strategies & Associates first reported a position in BLPH in Q3 2023 and held it in 1 quarter. The position peaked at $20 in Q3 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

Global Wealth Strategies & Associates reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
Global Wealth Strategies & Associates sold 50 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $20.
Global Wealth Strategies & Associates first reported a position in Bellerophon Therapeutics, Inc. in Q3 2023 and held it in 1 quarter.
Global Wealth Strategies & Associates's Bellerophon Therapeutics, Inc. position peaked at $20 in Q3 2023.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Global Wealth Strategies & Associates's 13F filing for Q4 2023, filed 2 Jan 2024.